FGF21 functions as an endocrine hormone with anti-inflammatory, anti-diabetic, and anti-obesity effects and is produced in peripheral tissues (e.g., liver, white and brown adipose tissues, skeletal muscle, and pancreas) [11]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.